GLASEEQ Trademark

Trademark Overview

On Tuesday, June 3, 2008, a trademark application was filed for GLASEEQ with the United States Patent and Trademark Office. The USPTO has given the GLASEEQ trademark a serial number of 79054845. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, May 7, 2024. This trademark is owned by NOVARTIS AG. The GLASEEQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular and metabolic system including diabetes, the respiratory system, the genitourinary system, for the treatment of musculo-skeletal and inflammatory disorders, or used in dermatology, oncology, haematology and in tissue and organ transplantation, in ophthalmology; pharmaceutical preparations for gastroenterological disorders, for the prevention and treatment of ocular disorders; for the treatment of bacteria-based diseases, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines
glaseeq

General Information

Serial Number79054845
Word MarkGLASEEQ
Filing DateTuesday, June 3, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, May 7, 2024
Registration Number3580832
Registration DateTuesday, February 24, 2009
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 9, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular and metabolic system including diabetes, the respiratory system, the genitourinary system, for the treatment of musculo-skeletal and inflammatory disorders, or used in dermatology, oncology, haematology and in tissue and organ transplantation, in ophthalmology; pharmaceutical preparations for gastroenterological disorders, for the prevention and treatment of ocular disorders; for the treatment of bacteria-based diseases, anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, May 14, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Monday, September 15, 2008ASSIGNED TO EXAMINER
Thursday, July 17, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 18, 2008LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Monday, July 21, 2008NEW APPLICATION ENTERED
Monday, September 15, 2008NON-FINAL ACTION WRITTEN
Tuesday, September 16, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 16, 2008REFUSAL PROCESSED BY MPU
Tuesday, September 16, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 29, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 29, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 3, 2008REFUSAL PROCESSED BY IB
Thursday, October 16, 2008EXAMINERS AMENDMENT -WRITTEN
Thursday, October 16, 2008EXAMINERS AMENDMENT E-MAILED
Thursday, October 16, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 16, 2008ASSIGNED TO LIE
Thursday, October 16, 2008EXAMINER'S AMENDMENT ENTERED
Monday, October 27, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 4, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 19, 2008NOTICE OF PUBLICATION
Tuesday, December 9, 2008PUBLISHED FOR OPPOSITION
Tuesday, February 24, 2009REGISTERED-PRINCIPAL REGISTER
Thursday, June 25, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 25, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, June 8, 2009FINAL DISPOSITION PROCESSED
Monday, June 8, 2009FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 28, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Monday, June 1, 2015DEATH OF INTERNATIONAL REGISTRATION
Monday, June 1, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, August 28, 2015NOTIFICATION PROCESSED BY IB
Friday, June 22, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, June 22, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, March 1, 2019NOTIFICATION PROCESSED BY IB
Tuesday, May 28, 2024DEATH OF INTERNATIONAL REGISTRATION
Tuesday, May 28, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Tuesday, May 28, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Related Keywords

glaseeq preparations system disorders treatment pharmaceutical prevention bacteria gastroenterological ocular transplantation